Europe - FRA:DC4 - US2521311074 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to DC4.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-08-02 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-07-30 | Oppenheimer | Maintains | Outperform |
| 2021-07-30 | SVB Leerink | Maintains | Outperform |
| 2021-07-30 | Wells Fargo | Maintains | Equal-Weight |
| 2021-07-30 | Raymond James | Maintains | Outperform |
| 2021-07-30 | Canaccord Genuity | Maintains | Buy |
| 2021-07-30 | Piper Sandler | Maintains | Overweight |
| 2021-05-28 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2021-05-25 | Barclays | Initiate | Overweight |
| 2021-04-30 | Raymond James | Maintains | Outperform |
| 2021-04-30 | Canaccord Genuity | Maintains | Buy |
| 2021-04-30 | Citigroup | Maintains | Buy |
| 2021-04-15 | Atlantic Equities | Initiate | Overweight |
| 2021-02-12 | Raymond James | Maintains | Outperform |
| 2021-02-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-02-12 | Citigroup | Maintains | Buy |
35 analysts have analysed DC4.DE and the average price target is 89.5 EUR. This implies a price increase of 51.7% is expected in the next year compared to the current price of 59.
The consensus rating for DEXCOM INC (DC4.DE) is 84.5714 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering DEXCOM INC (DC4.DE) is 35.